AiCure to Debut the H.Code Platform at DPHARM
AiCure, known for applying AI and data analytics to understand patient behavior, will sponsor the annual DPHARM conference. At this year’s event, the company will introduce H.Code, a new platform designed to make patient engagement in clinical trials clearer, simpler, and more consistent.
How H.Code Works
H.Code brings together advanced capabilities—computer vision paired with app-based communication—to give site teams practical tools to see, understand, and anticipate participant behaviors throughout a study. The platform centers on improving adherence and enabling dependable digital assessments. By organizing these functions in one place, H.Code aims to support better decision-making and, ultimately, stronger outcomes in precision medicine.
Hear from AiCure’s CEO at DPHARM
Ed Ikeguchi, AiCure’s CEO, will share insights during his DPHARM session, “From Chaos to Clarity: Simplifying Trial Participation with a Single Platform.” The talk focuses on how using one unified platform can streamline trial operations end to end—reducing friction for participants while making work more straightforward for sites and sponsors.
Designing a Better Participant Experience
Ikeguchi will discuss folding trial tasks into participants’ everyday routines, so people don’t have to juggle multiple apps, devices, and portals. Fewer moving parts means less confusion and fewer missed steps. The goal is a smoother, less chaotic experience for participants—and, in turn, clearer execution for site teams.
Meet AiCure at Booth #46
Attendees can visit AiCure at Booth #46 to talk directly with the team about H.Code. It’s a chance to ask questions, see how the platform could align with ongoing or upcoming studies, and consider where a single, integrated approach might support trial outcomes.
Leadership Update at AiCure
AiCure has promoted Josh Wilson to Chief Operating Officer (COO). In this role, he will lead product management and operational functions, advancing initiatives that support AiCure’s mission to streamline clinical trials and improve the participant experience through focused, practical technology.
Josh Wilson’s Background and Contribution
Wilson joined AiCure in 2022 as Senior Vice President of Operations after serving in leadership roles at prominent CROs. His experience in data management and operational strategy has been central to scaling AiCure’s impact and refining how the company delivers its platform services to sponsors and sites.
A Note from Leadership
Ed Ikeguchi highlighted Wilson’s leadership and expertise, emphasizing that the move to COO reflects AiCure’s confidence in his ability to guide the company’s next phase of growth while encouraging continued innovation.
About AiCure
AiCure focuses on simplifying the clinical trial experience with H.Code—a platform that combines AI-driven tools for dosing and compliance with straightforward, in-app communication. By bringing these capabilities together, the all-in-one approach aims to make participation more accessible and satisfying for patients and easier to manage for sites and sponsors. To learn more about AiCure’s work to improve clinical trials, visit www.aicure.com.
Frequently Asked Questions
What is H.Code?
H.Code is AiCure’s platform that uses AI, computer vision, and app-based communication to support participant engagement and adherence in clinical trials while enabling reliable digital assessments.
Who is presenting at DPHARM, and what will the talk cover?
AiCure’s CEO, Ed Ikeguchi, will present “From Chaos to Clarity: Simplifying Trial Participation with a Single Platform,” focusing on how one unified platform can streamline trials for participants, site teams, and sponsors.
Where can I learn more about AiCure?
You can find more information on AiCure’s website at www.aicure.com.
What will Josh Wilson do as COO?
As COO, Josh Wilson will oversee product management and operations, driving initiatives that advance AiCure’s mission to simplify clinical trials and enhance the participant experience.
How does AiCure aim to improve the participant experience?
AiCure focuses on integrating trial protocols into daily routines and reducing the need to manage multiple technologies, so participants, sites, and sponsors can work through a single platform with less friction.
